Clinical Trial: Safety/Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in ALS

Press/Media: Press / Media

Period2017 Jul 17

Media coverage

1

Media coverage

  • TitleClinical Trial: Safety/Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in ALS
    Media name/outletHealth Daily Digest (Ht Media)
    CountryIndia
    Date17/7/17
    PersonsSeung Hyun Kim